

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.94663421 |
| 2 | central nervous system myelination (GO:0022010) | 8.94663421 |
| 3 | fatty acid elongation (GO:0030497) | 6.41389236 |
| 4 | proteasome assembly (GO:0043248) | 5.31210598 |
| 5 | chaperone-mediated protein transport (GO:0072321) | 5.29863896 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 5.04701925 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.04701925 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.01323975 |
| 9 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.83651584 |
| 10 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.76488268 |
| 11 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.76455127 |
| 12 | presynaptic membrane assembly (GO:0097105) | 4.29518651 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 4.28710149 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.28710149 |
| 15 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.28710149 |
| 16 | presynaptic membrane organization (GO:0097090) | 4.19869165 |
| 17 | respiratory electron transport chain (GO:0022904) | 4.13077717 |
| 18 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.11352210 |
| 19 | protein maturation by protein folding (GO:0022417) | 4.06625607 |
| 20 | electron transport chain (GO:0022900) | 4.00457450 |
| 21 | protein neddylation (GO:0045116) | 3.98573814 |
| 22 | ensheathment of neurons (GO:0007272) | 3.97618901 |
| 23 | axon ensheathment (GO:0008366) | 3.97618901 |
| 24 | myelination (GO:0042552) | 3.97363286 |
| 25 | positive regulation of mitochondrial fission (GO:0090141) | 3.96226095 |
| 26 | protein complex biogenesis (GO:0070271) | 3.96191119 |
| 27 | ribosomal large subunit biogenesis (GO:0042273) | 3.91853610 |
| 28 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.91636096 |
| 29 | cholesterol biosynthetic process (GO:0006695) | 3.90425601 |
| 30 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.89414431 |
| 31 | negative regulation of neurotransmitter transport (GO:0051589) | 3.88679979 |
| 32 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.87356090 |
| 33 | negative regulation of ligase activity (GO:0051352) | 3.85645408 |
| 34 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.85645408 |
| 35 | GPI anchor biosynthetic process (GO:0006506) | 3.83796413 |
| 36 | isoprenoid biosynthetic process (GO:0008299) | 3.82936061 |
| 37 | respiratory chain complex IV assembly (GO:0008535) | 3.81439649 |
| 38 | oxidative phosphorylation (GO:0006119) | 3.80667956 |
| 39 | negative regulation of protein localization to cell surface (GO:2000009) | 3.76648878 |
| 40 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.75353288 |
| 41 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.75220867 |
| 42 | regulation of mitochondrial translation (GO:0070129) | 3.70276478 |
| 43 | peptidyl-histidine modification (GO:0018202) | 3.70191423 |
| 44 | ribosome assembly (GO:0042255) | 3.69708093 |
| 45 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.66339462 |
| 46 | protein targeting to mitochondrion (GO:0006626) | 3.60623039 |
| 47 | response to methylmercury (GO:0051597) | 3.59773330 |
| 48 | ribosomal small subunit biogenesis (GO:0042274) | 3.57764691 |
| 49 | mannosylation (GO:0097502) | 3.57072155 |
| 50 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.51590504 |
| 51 | glycerophospholipid catabolic process (GO:0046475) | 3.51583398 |
| 52 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.50918860 |
| 53 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.48814573 |
| 54 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.48292937 |
| 55 | sterol biosynthetic process (GO:0016126) | 3.48045029 |
| 56 | CENP-A containing nucleosome assembly (GO:0034080) | 3.45436763 |
| 57 | neurotransmitter uptake (GO:0001504) | 3.44764646 |
| 58 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.44426603 |
| 59 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.42337953 |
| 60 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.42242450 |
| 61 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.42242450 |
| 62 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.39898000 |
| 63 | establishment of mitochondrion localization (GO:0051654) | 3.39633470 |
| 64 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.38779988 |
| 65 | GPI anchor metabolic process (GO:0006505) | 3.37793681 |
| 66 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.37263874 |
| 67 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.37263874 |
| 68 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.37263874 |
| 69 | regulation of somitogenesis (GO:0014807) | 3.36965458 |
| 70 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.36212790 |
| 71 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.35392465 |
| 72 | amyloid precursor protein metabolic process (GO:0042982) | 3.33912619 |
| 73 | purine nucleotide salvage (GO:0032261) | 3.33428677 |
| 74 | formation of translation preinitiation complex (GO:0001731) | 3.30611201 |
| 75 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.29108433 |
| 76 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.29108433 |
| 77 | termination of RNA polymerase III transcription (GO:0006386) | 3.27686894 |
| 78 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.27686894 |
| 79 | establishment of protein localization to mitochondrion (GO:0072655) | 3.26286278 |
| 80 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.25191995 |
| 81 | positive regulation of ligase activity (GO:0051351) | 3.24823552 |
| 82 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.23621309 |
| 83 | signal peptide processing (GO:0006465) | 3.21503778 |
| 84 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.20458443 |
| 85 | chromatin remodeling at centromere (GO:0031055) | 3.19552939 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.19289925 |
| 87 | protein targeting to ER (GO:0045047) | 3.18011804 |
| 88 | cotranslational protein targeting to membrane (GO:0006613) | 3.17392065 |
| 89 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.17109942 |
| 90 | amyloid precursor protein catabolic process (GO:0042987) | 3.16948059 |
| 91 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.16498313 |
| 92 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.16498313 |
| 93 | viral transcription (GO:0019083) | 3.15901601 |
| 94 | regulation of mitochondrial fission (GO:0090140) | 3.15172496 |
| 95 | protein localization to mitochondrion (GO:0070585) | 3.14549290 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.09862978 |
| 97 | magnesium ion transport (GO:0015693) | 3.08765283 |
| 98 | purine nucleobase biosynthetic process (GO:0009113) | 3.08383658 |
| 99 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.06773129 |
| 100 | regulation of ligase activity (GO:0051340) | 3.06585425 |
| 101 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.06243596 |
| 102 | translation (GO:0006412) | 3.06079231 |
| 103 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.05365633 |
| 104 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.04681106 |
| 105 | protein localization to endoplasmic reticulum (GO:0070972) | 3.04431831 |
| 106 | viral protein processing (GO:0019082) | 3.03728030 |
| 107 | cullin deneddylation (GO:0010388) | 3.03723410 |
| 108 | viral mRNA export from host cell nucleus (GO:0046784) | 3.03017710 |
| 109 | inner mitochondrial membrane organization (GO:0007007) | 3.01269847 |
| 110 | positive regulation of action potential (GO:0045760) | 3.01141714 |
| 111 | neuron cell-cell adhesion (GO:0007158) | 2.99802815 |
| 112 | DNA strand elongation (GO:0022616) | 2.99718953 |
| 113 | translational termination (GO:0006415) | 2.99173838 |
| 114 | spliceosomal snRNP assembly (GO:0000387) | 2.98068573 |
| 115 | nucleotide transmembrane transport (GO:1901679) | 2.96769891 |
| 116 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.93828391 |
| 117 | tricarboxylic acid cycle (GO:0006099) | 2.93518041 |
| 118 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.93504047 |
| 119 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.92167269 |
| 120 | myelin maintenance (GO:0043217) | 2.91772915 |
| 121 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.91615738 |
| 122 | ventricular cardiac muscle cell development (GO:0055015) | 2.90781481 |
| 123 | substantia nigra development (GO:0021762) | 2.90512851 |
| 124 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.89420563 |
| 125 | response to redox state (GO:0051775) | 2.88046400 |
| 126 | translational elongation (GO:0006414) | 2.87792039 |
| 127 | rRNA modification (GO:0000154) | 2.87331101 |
| 128 | transcription from mitochondrial promoter (GO:0006390) | 2.86818353 |
| 129 | regulation of collateral sprouting (GO:0048670) | 2.86608223 |
| 130 | DNA ligation (GO:0006266) | 2.86239912 |
| 131 | cytochrome complex assembly (GO:0017004) | 2.86200234 |
| 132 | kinetochore organization (GO:0051383) | 2.86094008 |
| 133 | ribosomal small subunit assembly (GO:0000028) | 2.85829949 |
| 134 | aldehyde catabolic process (GO:0046185) | 2.84921326 |
| 135 | GTP biosynthetic process (GO:0006183) | 2.84254835 |
| 136 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.80428532 |
| 137 | cell cycle G1/S phase transition (GO:0044843) | 2.80210821 |
| 138 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.80210821 |
| 139 | AMP metabolic process (GO:0046033) | 2.78799007 |
| 140 | mitotic chromosome condensation (GO:0007076) | 2.77990044 |
| 141 | mitotic metaphase plate congression (GO:0007080) | 2.77257125 |
| 142 | positive regulation of protein homodimerization activity (GO:0090073) | 2.76837271 |
| 143 | purine-containing compound salvage (GO:0043101) | 2.76806453 |
| 144 | oligodendrocyte differentiation (GO:0048709) | 2.76052495 |
| 145 | telomere maintenance via recombination (GO:0000722) | 2.75717757 |
| 146 | positive regulation of cell cycle arrest (GO:0071158) | 2.75273141 |
| 147 | limb bud formation (GO:0060174) | 2.74912876 |
| 148 | regulation of catecholamine metabolic process (GO:0042069) | 2.74680127 |
| 149 | regulation of dopamine metabolic process (GO:0042053) | 2.74680127 |
| 150 | galactose catabolic process (GO:0019388) | 2.74370158 |
| 151 | L-fucose catabolic process (GO:0042355) | 2.72003634 |
| 152 | fucose catabolic process (GO:0019317) | 2.72003634 |
| 153 | L-fucose metabolic process (GO:0042354) | 2.72003634 |
| 154 | mitochondrial transport (GO:0006839) | 2.71953951 |
| 155 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.71335996 |
| 156 | protein deneddylation (GO:0000338) | 2.71079828 |
| 157 | establishment of integrated proviral latency (GO:0075713) | 2.69758342 |
| 158 | hydrogen ion transmembrane transport (GO:1902600) | 2.66885854 |
| 159 | mitochondrion morphogenesis (GO:0070584) | 2.66602094 |
| 160 | neuronal action potential propagation (GO:0019227) | 2.65264903 |
| 161 | regulation of lipoprotein metabolic process (GO:0050746) | 2.65152402 |
| 162 | protein palmitoylation (GO:0018345) | 2.61464593 |
| 163 | establishment of viral latency (GO:0019043) | 2.61432505 |
| 164 | photoreceptor cell differentiation (GO:0046530) | 2.61243023 |
| 165 | eye photoreceptor cell differentiation (GO:0001754) | 2.61243023 |
| 166 | fucosylation (GO:0036065) | 2.60905093 |
| 167 | ER overload response (GO:0006983) | 2.60058260 |
| 168 | proton transport (GO:0015992) | 2.57706043 |
| 169 | membrane assembly (GO:0071709) | 2.55848263 |
| 170 | C-terminal protein lipidation (GO:0006501) | 2.55791544 |
| 171 | dopamine transport (GO:0015872) | 2.55027926 |
| 172 | establishment of mitotic spindle orientation (GO:0000132) | 2.54940544 |
| 173 | apical protein localization (GO:0045176) | 2.53109106 |
| 174 | response to epinephrine (GO:0071871) | 2.52508538 |
| 175 | hydrogen transport (GO:0006818) | 2.49689664 |
| 176 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.49422354 |
| 177 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.48834016 |
| 178 | platelet dense granule organization (GO:0060155) | 2.47879447 |
| 179 | regulation of protein targeting to membrane (GO:0090313) | 2.47854042 |
| 180 | positive regulation of glial cell differentiation (GO:0045687) | 2.47607987 |
| 181 | aerobic respiration (GO:0009060) | 2.46588378 |
| 182 | protein polyglutamylation (GO:0018095) | 2.42172897 |
| 183 | centriole replication (GO:0007099) | 2.40945623 |
| 184 | peripheral nervous system neuron development (GO:0048935) | 2.40425855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.15828690 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.79676628 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.78457424 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.71951758 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.66574742 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.40322072 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.26857989 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.24664080 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.93219627 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.84812217 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84159533 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.82927697 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.77351002 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.73173040 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.69670949 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.67731404 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.61667993 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.60874667 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.56141980 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.55260694 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 2.52101262 |
| 22 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.44017074 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.42864771 |
| 24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.36862595 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.34550462 |
| 26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.31572379 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.20057250 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.19982280 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.17309721 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.14867581 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.13652616 |
| 32 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.12376837 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.02752732 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.00707136 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93209887 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.88992803 |
| 37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.88491767 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.88300379 |
| 39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.87753875 |
| 40 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.87601418 |
| 41 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.86472376 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81747056 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80943605 |
| 44 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.80448128 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.80068230 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79997114 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.78779415 |
| 48 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.78760535 |
| 49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77874156 |
| 50 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.76514782 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.74766538 |
| 52 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72627581 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72527695 |
| 54 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.71073145 |
| 55 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.67657506 |
| 56 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.66281394 |
| 57 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.65564781 |
| 58 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.63581551 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62735331 |
| 60 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.61842766 |
| 61 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60932007 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.60392346 |
| 63 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59619961 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59461880 |
| 65 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.59041120 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57898202 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57477126 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.57190745 |
| 69 | VDR_22108803_ChIP-Seq_LS180_Human | 1.54509830 |
| 70 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.53884645 |
| 71 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.53629836 |
| 72 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.53094942 |
| 73 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.53078722 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52286530 |
| 75 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.51943054 |
| 76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50639555 |
| 77 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50591386 |
| 78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.50344806 |
| 79 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49861646 |
| 80 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.47183332 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45109752 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44875745 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.43615323 |
| 84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.43607425 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.43311031 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42392716 |
| 87 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.42357925 |
| 88 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.41878918 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41557908 |
| 90 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39320190 |
| 91 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.38055455 |
| 92 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.37159032 |
| 93 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36904466 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36713453 |
| 95 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35560344 |
| 96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.34558292 |
| 97 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33718853 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33125701 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.32725239 |
| 100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.32713082 |
| 101 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.32261884 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32215501 |
| 103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32095532 |
| 104 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32000885 |
| 105 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31947782 |
| 106 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.31916603 |
| 107 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.30987268 |
| 108 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30858091 |
| 109 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.30506989 |
| 110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29971986 |
| 111 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29095079 |
| 112 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.28393756 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28282911 |
| 114 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.27765277 |
| 115 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27260592 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26469095 |
| 117 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26357676 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25149715 |
| 119 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25140824 |
| 120 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.24928821 |
| 121 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24861966 |
| 122 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.24580750 |
| 123 | JUN_21703547_ChIP-Seq_K562_Human | 1.24303910 |
| 124 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.23188505 |
| 125 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22982562 |
| 126 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22834726 |
| 127 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22571554 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22454845 |
| 129 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.21967637 |
| 130 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21727880 |
| 131 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.17263304 |
| 132 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.16544370 |
| 133 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16435044 |
| 134 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.16076875 |
| 135 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15450798 |
| 136 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.15409034 |
| 137 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.15409034 |
| 138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15393632 |
| 139 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14947117 |
| 140 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14772829 |
| 141 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14734580 |
| 142 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14310041 |
| 143 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14079618 |
| 144 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.13181549 |
| 145 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12773365 |
| 146 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11365444 |
| 147 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11129257 |
| 148 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.10826330 |
| 149 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10434692 |
| 150 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.10336795 |
| 151 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10248725 |
| 152 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09664808 |
| 153 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09515683 |
| 154 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.08773617 |
| 155 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08595554 |
| 156 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07345967 |
| 157 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06491867 |
| 158 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06456559 |
| 159 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.05976628 |
| 160 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05307926 |
| 161 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05153067 |
| 162 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05104152 |
| 163 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03892271 |
| 164 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.03378385 |
| 165 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03269488 |
| 166 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.03239199 |
| 167 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.02794351 |
| 168 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.02621099 |
| 169 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.02569283 |
| 170 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02057157 |
| 171 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00172636 |
| 172 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99710319 |
| 173 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96127818 |
| 174 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92394551 |
| 175 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.91914013 |
| 176 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91125374 |
| 177 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91034296 |
| 178 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.91027499 |
| 179 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91015375 |
| 180 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.90558825 |
| 181 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.90545542 |
| 182 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87671071 |
| 183 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.82831684 |
| 184 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80548961 |
| 185 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.80534591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001529_abnormal_vocalization | 4.06850060 |
| 2 | MP0003880_abnormal_central_pattern | 4.02682767 |
| 3 | MP0001905_abnormal_dopamine_level | 3.46964091 |
| 4 | MP0000920_abnormal_myelination | 3.31166558 |
| 5 | MP0000749_muscle_degeneration | 2.97755598 |
| 6 | MP0010094_abnormal_chromosome_stability | 2.88906119 |
| 7 | MP0001853_heart_inflammation | 2.64096279 |
| 8 | MP0004147_increased_porphyrin_level | 2.61368612 |
| 9 | MP0003077_abnormal_cell_cycle | 2.55404718 |
| 10 | MP0003111_abnormal_nucleus_morphology | 2.53671013 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.48643041 |
| 12 | MP0008058_abnormal_DNA_repair | 2.47904273 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.43497403 |
| 14 | MP0004270_analgesia | 2.40366735 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.39242423 |
| 16 | MP0004142_abnormal_muscle_tone | 2.34277853 |
| 17 | MP0003136_yellow_coat_color | 2.29627696 |
| 18 | MP0002272_abnormal_nervous_system | 2.26979581 |
| 19 | MP0003693_abnormal_embryo_hatching | 2.11501154 |
| 20 | MP0003786_premature_aging | 2.11172949 |
| 21 | MP0001485_abnormal_pinna_reflex | 2.05214663 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.00525742 |
| 23 | MP0008007_abnormal_cellular_replicative | 2.00462872 |
| 24 | MP0005330_cardiomyopathy | 2.00253633 |
| 25 | MP0002102_abnormal_ear_morphology | 1.99374355 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.96882135 |
| 27 | MP0002736_abnormal_nociception_after | 1.91349846 |
| 28 | MP0009745_abnormal_behavioral_response | 1.76576552 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.76306954 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.75708433 |
| 31 | MP0004742_abnormal_vestibular_system | 1.75391972 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.74213124 |
| 33 | MP0008932_abnormal_embryonic_tissue | 1.73140079 |
| 34 | MP0002064_seizures | 1.70250032 |
| 35 | MP0008260_abnormal_autophagy | 1.70148133 |
| 36 | MP0009379_abnormal_foot_pigmentation | 1.68283119 |
| 37 | MP0003724_increased_susceptibility_to | 1.67436837 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.63932441 |
| 39 | MP0001486_abnormal_startle_reflex | 1.61847850 |
| 40 | MP0005408_hypopigmentation | 1.60708803 |
| 41 | MP0003787_abnormal_imprinting | 1.60466566 |
| 42 | MP0004043_abnormal_pH_regulation | 1.55106534 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.55090008 |
| 44 | MP0001661_extended_life_span | 1.51549803 |
| 45 | MP0000372_irregular_coat_pigmentation | 1.51330719 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.49596706 |
| 47 | MP0000747_muscle_weakness | 1.49438716 |
| 48 | MP0005379_endocrine/exocrine_gland_phen | 1.48413592 |
| 49 | MP0000751_myopathy | 1.48315086 |
| 50 | MP0000015_abnormal_ear_pigmentation | 1.46921163 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.46528165 |
| 52 | MP0005165_increased_susceptibility_to | 1.46287406 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.44713405 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.44387082 |
| 55 | MP0004885_abnormal_endolymph | 1.44365164 |
| 56 | MP0002269_muscular_atrophy | 1.44307191 |
| 57 | MP0004036_abnormal_muscle_relaxation | 1.43838193 |
| 58 | MP0001984_abnormal_olfaction | 1.43533012 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.42431744 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.42217945 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.42122738 |
| 62 | MP0009785_altered_susceptibility_to | 1.39594144 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.39457907 |
| 64 | MP0000778_abnormal_nervous_system | 1.38531355 |
| 65 | MP0009840_abnormal_foam_cell | 1.37387476 |
| 66 | MP0001764_abnormal_homeostasis | 1.36859808 |
| 67 | MP0002572_abnormal_emotion/affect_behav | 1.35457004 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.34835378 |
| 69 | MP0009046_muscle_twitch | 1.34834694 |
| 70 | MP0001963_abnormal_hearing_physiology | 1.34533675 |
| 71 | MP0004924_abnormal_behavior | 1.31268894 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.31268894 |
| 73 | MP0001440_abnormal_grooming_behavior | 1.30647543 |
| 74 | MP0000358_abnormal_cell_content/ | 1.30098334 |
| 75 | MP0005451_abnormal_body_composition | 1.29911184 |
| 76 | MP0005623_abnormal_meninges_morphology | 1.28506323 |
| 77 | MP0004134_abnormal_chest_morphology | 1.27969998 |
| 78 | MP0000343_altered_response_to | 1.27867485 |
| 79 | MP0003718_maternal_effect | 1.27452520 |
| 80 | MP0002067_abnormal_sensory_capabilities | 1.27168445 |
| 81 | MP0001970_abnormal_pain_threshold | 1.26856563 |
| 82 | MP0003950_abnormal_plasma_membrane | 1.25618936 |
| 83 | MP0002229_neurodegeneration | 1.25572816 |
| 84 | MP0002163_abnormal_gland_morphology | 1.25372190 |
| 85 | MP0001188_hyperpigmentation | 1.24728370 |
| 86 | MP0000750_abnormal_muscle_regeneration | 1.24168000 |
| 87 | MP0001730_embryonic_growth_arrest | 1.22859198 |
| 88 | MP0006292_abnormal_olfactory_placode | 1.22602596 |
| 89 | MP0005332_abnormal_amino_acid | 1.22031337 |
| 90 | MP0006072_abnormal_retinal_apoptosis | 1.21633681 |
| 91 | MP0010030_abnormal_orbit_morphology | 1.17233838 |
| 92 | MP0000759_abnormal_skeletal_muscle | 1.16115762 |
| 93 | MP0003329_amyloid_beta_deposits | 1.15938853 |
| 94 | MP0002063_abnormal_learning/memory/cond | 1.15111693 |
| 95 | MP0002876_abnormal_thyroid_physiology | 1.14598678 |
| 96 | MP0005409_darkened_coat_color | 1.13497362 |
| 97 | MP0009250_abnormal_appendicular_skeleto | 1.12409295 |
| 98 | MP0009697_abnormal_copulation | 1.12349904 |
| 99 | MP0001727_abnormal_embryo_implantation | 1.09393670 |
| 100 | MP0000313_abnormal_cell_death | 1.07598616 |
| 101 | MP0005423_abnormal_somatic_nervous | 1.07504224 |
| 102 | MP0003690_abnormal_glial_cell | 1.06806593 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 1.06705417 |
| 104 | MP0004087_abnormal_muscle_fiber | 1.06314982 |
| 105 | MP0003634_abnormal_glial_cell | 1.04884535 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 1.04294593 |
| 107 | MP0000350_abnormal_cell_proliferation | 1.04175326 |
| 108 | MP0005410_abnormal_fertilization | 1.02994384 |
| 109 | MP0003632_abnormal_nervous_system | 1.02473944 |
| 110 | MP0010307_abnormal_tumor_latency | 1.02143807 |
| 111 | MP0004859_abnormal_synaptic_plasticity | 1.01781333 |
| 112 | MP0008469_abnormal_protein_level | 1.00744731 |
| 113 | MP0003631_nervous_system_phenotype | 1.00015066 |
| 114 | MP0004381_abnormal_hair_follicle | 0.99289622 |
| 115 | MP0000026_abnormal_inner_ear | 0.98413529 |
| 116 | MP0004084_abnormal_cardiac_muscle | 0.97918620 |
| 117 | MP0001835_abnormal_antigen_presentation | 0.97832203 |
| 118 | MP0002752_abnormal_somatic_nervous | 0.97801516 |
| 119 | MP0003938_abnormal_ear_development | 0.97082895 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.96704738 |
| 121 | MP0002452_abnormal_antigen_presenting | 0.95063921 |
| 122 | MP0002733_abnormal_thermal_nociception | 0.94664487 |
| 123 | MP0002938_white_spotting | 0.94112552 |
| 124 | MP0001790_abnormal_immune_system | 0.93746827 |
| 125 | MP0005387_immune_system_phenotype | 0.93746827 |
| 126 | MP0003633_abnormal_nervous_system | 0.91968913 |
| 127 | MP0008004_abnormal_stomach_pH | 0.91613922 |
| 128 | MP0008877_abnormal_DNA_methylation | 0.90950819 |
| 129 | MP0010386_abnormal_urinary_bladder | 0.89761994 |
| 130 | MP0002882_abnormal_neuron_morphology | 0.89462813 |
| 131 | MP0001501_abnormal_sleep_pattern | 0.89209431 |
| 132 | MP0000465_gastrointestinal_hemorrhage | 0.89046425 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.88524528 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.88098148 |
| 135 | MP0005000_abnormal_immune_tolerance | 0.87928503 |
| 136 | MP0000858_altered_metastatic_potential | 0.86831166 |
| 137 | MP0002019_abnormal_tumor_incidence | 0.86610114 |
| 138 | MP0002249_abnormal_larynx_morphology | 0.86259466 |
| 139 | MP0003172_abnormal_lysosome_physiology | 0.86234507 |
| 140 | MP0008057_abnormal_DNA_replication | 0.84451135 |
| 141 | MP0000733_abnormal_muscle_development | 0.83713595 |
| 142 | MP0004510_myositis | 0.82680252 |
| 143 | MP0002972_abnormal_cardiac_muscle | 0.81656429 |
| 144 | MP0003075_altered_response_to | 0.81567731 |
| 145 | MP0002066_abnormal_motor_capabilities/c | 0.80828121 |
| 146 | MP0001851_eye_inflammation | 0.80815987 |
| 147 | MP0001697_abnormal_embryo_size | 0.80811137 |
| 148 | MP0002210_abnormal_sex_determination | 0.80211807 |
| 149 | MP0005171_absent_coat_pigmentation | 0.79592505 |
| 150 | MP0002132_abnormal_respiratory_system | 0.79443798 |
| 151 | MP0003195_calcinosis | 0.79313012 |
| 152 | MP0002723_abnormal_immune_serum | 0.78519752 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.78183733 |
| 154 | MP0004233_abnormal_muscle_weight | 0.77850056 |
| 155 | MP0001800_abnormal_humoral_immune | 0.77461566 |
| 156 | MP0002095_abnormal_skin_pigmentation | 0.77209911 |
| 157 | MP0003121_genomic_imprinting | 0.77059089 |
| 158 | MP0004215_abnormal_myocardial_fiber | 0.76473503 |
| 159 | MP0005195_abnormal_posterior_eye | 0.75594187 |
| 160 | MP0001346_abnormal_lacrimal_gland | 0.74982983 |
| 161 | MP0000955_abnormal_spinal_cord | 0.74619761 |
| 162 | MP0005670_abnormal_white_adipose | 0.74230572 |
| 163 | MP0005253_abnormal_eye_physiology | 0.74114542 |
| 164 | MP0003448_altered_tumor_morphology | 0.70726917 |
| 165 | MP0000013_abnormal_adipose_tissue | 0.70376301 |
| 166 | MP0004484_altered_response_of | 0.69913021 |
| 167 | MP0005266_abnormal_metabolism | 0.69286258 |
| 168 | MP0003941_abnormal_skin_development | 0.69229686 |
| 169 | MP0002106_abnormal_muscle_physiology | 0.68897436 |
| 170 | MP0005464_abnormal_platelet_physiology | 0.68724762 |
| 171 | MP0002933_joint_inflammation | 0.68660956 |
| 172 | MP0008873_increased_physiological_sensi | 0.68593610 |
| 173 | MP0000689_abnormal_spleen_morphology | 0.68554490 |
| 174 | MP0001929_abnormal_gametogenesis | 0.67883340 |
| 175 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67777903 |
| 176 | MP0005671_abnormal_response_to | 0.67637466 |
| 177 | MP0001243_abnormal_dermal_layer | 0.67145749 |
| 178 | MP0005023_abnormal_wound_healing | 0.67110819 |
| 179 | MP0003186_abnormal_redox_activity | 0.67002176 |
| 180 | MP0002420_abnormal_adaptive_immunity | 0.66647532 |
| 181 | MP0002822_catalepsy | 0.66245956 |
| 182 | MP0008569_lethality_at_weaning | 0.65538808 |
| 183 | MP0000681_abnormal_thyroid_gland | 0.65441429 |
| 184 | MP0002295_abnormal_pulmonary_circulatio | 0.64795336 |
| 185 | MP0002184_abnormal_innervation | 0.63947740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.40957732 |
| 2 | Increased hepatocellular lipid droplets (HP:0006565) | 4.22058665 |
| 3 | Increased serum pyruvate (HP:0003542) | 4.20554244 |
| 4 | Abnormality of glycolysis (HP:0004366) | 4.20554244 |
| 5 | Renal Fanconi syndrome (HP:0001994) | 4.02174309 |
| 6 | Mitochondrial inheritance (HP:0001427) | 3.93927099 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.80992750 |
| 8 | Acute encephalopathy (HP:0006846) | 3.79002040 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.78185060 |
| 10 | 3-Methylglutaconic aciduria (HP:0003535) | 3.77548101 |
| 11 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.72992248 |
| 12 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.72992248 |
| 13 | Lipid accumulation in hepatocytes (HP:0006561) | 3.61235223 |
| 14 | Type I transferrin isoform profile (HP:0003642) | 3.40389871 |
| 15 | Parakeratosis (HP:0001036) | 3.40067076 |
| 16 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.39314785 |
| 17 | Hepatocellular necrosis (HP:0001404) | 3.35682112 |
| 18 | Increased CSF lactate (HP:0002490) | 3.34053652 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.26944596 |
| 20 | Retinal dysplasia (HP:0007973) | 3.21734906 |
| 21 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.08081944 |
| 22 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.07543985 |
| 23 | Aplastic anemia (HP:0001915) | 3.05140047 |
| 24 | Nemaline bodies (HP:0003798) | 3.01605060 |
| 25 | Leukodystrophy (HP:0002415) | 2.92045460 |
| 26 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.91662054 |
| 27 | Calf muscle hypertrophy (HP:0008981) | 2.88542393 |
| 28 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.84504036 |
| 29 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.84504036 |
| 30 | Abnormal protein glycosylation (HP:0012346) | 2.84504036 |
| 31 | Abnormal glycosylation (HP:0012345) | 2.84504036 |
| 32 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.82386102 |
| 33 | Reduced antithrombin III activity (HP:0001976) | 2.81215051 |
| 34 | Progressive muscle weakness (HP:0003323) | 2.80980220 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.79874622 |
| 36 | Sensory axonal neuropathy (HP:0003390) | 2.77819809 |
| 37 | Microvesicular hepatic steatosis (HP:0001414) | 2.75838881 |
| 38 | Neurofibrillary tangles (HP:0002185) | 2.73111219 |
| 39 | Muscle fiber inclusion bodies (HP:0100299) | 2.72124871 |
| 40 | Exertional dyspnea (HP:0002875) | 2.71903779 |
| 41 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.71336741 |
| 42 | Increased intramyocellular lipid droplets (HP:0012240) | 2.68202763 |
| 43 | Hypothermia (HP:0002045) | 2.61672128 |
| 44 | Abnormality of renal resorption (HP:0011038) | 2.60196003 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.59354875 |
| 46 | Hepatic necrosis (HP:0002605) | 2.56735277 |
| 47 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.51781317 |
| 48 | Abnormal hair whorl (HP:0010721) | 2.50362504 |
| 49 | Rough bone trabeculation (HP:0100670) | 2.50306703 |
| 50 | Ragged-red muscle fibers (HP:0003200) | 2.45139848 |
| 51 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.39561673 |
| 52 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.39561673 |
| 53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39426375 |
| 54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39426375 |
| 55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39426375 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36846798 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.36846798 |
| 58 | Medial flaring of the eyebrow (HP:0010747) | 2.36806823 |
| 59 | Myoglobinuria (HP:0002913) | 2.34825447 |
| 60 | Testicular atrophy (HP:0000029) | 2.34402973 |
| 61 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.34190926 |
| 62 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.34052139 |
| 63 | Lactic acidosis (HP:0003128) | 2.33593121 |
| 64 | Absent/shortened dynein arms (HP:0200106) | 2.33162221 |
| 65 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.33162221 |
| 66 | Nausea (HP:0002018) | 2.32564316 |
| 67 | Methylmalonic acidemia (HP:0002912) | 2.30000454 |
| 68 | Muscle fiber splitting (HP:0003555) | 2.29063869 |
| 69 | Abnormality of placental membranes (HP:0011409) | 2.28991650 |
| 70 | Amniotic constriction ring (HP:0009775) | 2.28991650 |
| 71 | Oral leukoplakia (HP:0002745) | 2.27617175 |
| 72 | Hepatosplenomegaly (HP:0001433) | 2.27556061 |
| 73 | Macrocytic anemia (HP:0001972) | 2.26635467 |
| 74 | Optic disc pallor (HP:0000543) | 2.24662655 |
| 75 | Abnormal number of erythroid precursors (HP:0012131) | 2.23518206 |
| 76 | Abnormality of the corticospinal tract (HP:0002492) | 2.22522512 |
| 77 | Pancytopenia (HP:0001876) | 2.22362541 |
| 78 | Cerebral edema (HP:0002181) | 2.21835017 |
| 79 | Respiratory failure (HP:0002878) | 2.20837949 |
| 80 | Hypoplastic left heart (HP:0004383) | 2.20139160 |
| 81 | Nonprogressive disorder (HP:0003680) | 2.20056907 |
| 82 | Cerebral hemorrhage (HP:0001342) | 2.19414882 |
| 83 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.18737496 |
| 84 | Albinism (HP:0001022) | 2.18296222 |
| 85 | Stenosis of the external auditory canal (HP:0000402) | 2.17840252 |
| 86 | True hermaphroditism (HP:0010459) | 2.16876240 |
| 87 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.16215112 |
| 88 | Abnormal ciliary motility (HP:0012262) | 2.15642015 |
| 89 | Increased serum lactate (HP:0002151) | 2.14730863 |
| 90 | Exercise intolerance (HP:0003546) | 2.13380263 |
| 91 | Lethargy (HP:0001254) | 2.13197732 |
| 92 | Cerebral hypomyelination (HP:0006808) | 2.12921614 |
| 93 | Abnormality of the anterior horn cell (HP:0006802) | 2.11518105 |
| 94 | Degeneration of anterior horn cells (HP:0002398) | 2.11518105 |
| 95 | Pancreatic fibrosis (HP:0100732) | 2.09320971 |
| 96 | Autoamputation (HP:0001218) | 2.09129399 |
| 97 | Exercise-induced myalgia (HP:0003738) | 2.08429696 |
| 98 | Respiratory difficulties (HP:0002880) | 2.07995851 |
| 99 | Abnormality of methionine metabolism (HP:0010901) | 2.07168822 |
| 100 | Rimmed vacuoles (HP:0003805) | 2.07083332 |
| 101 | Gonadal dysgenesis (HP:0000133) | 2.04833921 |
| 102 | EMG: myopathic abnormalities (HP:0003458) | 2.04759748 |
| 103 | Increased muscle lipid content (HP:0009058) | 2.04190029 |
| 104 | Asplenia (HP:0001746) | 2.04142075 |
| 105 | Hypoplastic heart (HP:0001961) | 2.03863665 |
| 106 | Abnormal trabecular bone morphology (HP:0100671) | 2.03332145 |
| 107 | Reticulocytopenia (HP:0001896) | 2.00913284 |
| 108 | Abnormality of the renal collecting system (HP:0004742) | 1.99959613 |
| 109 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.99193839 |
| 110 | Peripheral hypomyelination (HP:0007182) | 1.98863384 |
| 111 | Multiple enchondromatosis (HP:0005701) | 1.97316936 |
| 112 | Abnormality of the umbilical cord (HP:0010881) | 1.97083033 |
| 113 | Male pseudohermaphroditism (HP:0000037) | 1.96536132 |
| 114 | CNS demyelination (HP:0007305) | 1.96497596 |
| 115 | Vacuolated lymphocytes (HP:0001922) | 1.95729174 |
| 116 | Palpitations (HP:0001962) | 1.92634681 |
| 117 | Chin dimple (HP:0010751) | 1.92237924 |
| 118 | Prolonged neonatal jaundice (HP:0006579) | 1.90983367 |
| 119 | Systemic lupus erythematosus (HP:0002725) | 1.90344901 |
| 120 | Neoplasm of head and neck (HP:0012288) | 1.89851497 |
| 121 | Esophageal neoplasm (HP:0100751) | 1.89851497 |
| 122 | Type II lissencephaly (HP:0007260) | 1.89669479 |
| 123 | Neck muscle weakness (HP:0000467) | 1.89399285 |
| 124 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.88007085 |
| 125 | Hypoglycemic coma (HP:0001325) | 1.87031097 |
| 126 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.86245050 |
| 127 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.86185513 |
| 128 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.85009997 |
| 129 | Progressive neurologic deterioration (HP:0002344) | 1.84767379 |
| 130 | CNS hypomyelination (HP:0003429) | 1.82883247 |
| 131 | X-linked dominant inheritance (HP:0001423) | 1.82507210 |
| 132 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.82451610 |
| 133 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.82451610 |
| 134 | Weak cry (HP:0001612) | 1.82376417 |
| 135 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.81863023 |
| 136 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.81863023 |
| 137 | Single umbilical artery (HP:0001195) | 1.81863023 |
| 138 | Thickened helices (HP:0000391) | 1.80964562 |
| 139 | Absent septum pellucidum (HP:0001331) | 1.80265033 |
| 140 | Cupped ear (HP:0000378) | 1.79582738 |
| 141 | Methylmalonic aciduria (HP:0012120) | 1.78976597 |
| 142 | Vaginal atresia (HP:0000148) | 1.77712610 |
| 143 | Morphological abnormality of the inner ear (HP:0011390) | 1.77493998 |
| 144 | Muscle stiffness (HP:0003552) | 1.76549382 |
| 145 | Genital tract atresia (HP:0001827) | 1.76470276 |
| 146 | Abnormal gallbladder physiology (HP:0012438) | 1.76012225 |
| 147 | Tubulointerstitial nephritis (HP:0001970) | 1.74974720 |
| 148 | Stridor (HP:0010307) | 1.74736701 |
| 149 | Diastasis recti (HP:0001540) | 1.74516698 |
| 150 | Polydipsia (HP:0001959) | 1.74459106 |
| 151 | Abnormal drinking behavior (HP:0030082) | 1.74459106 |
| 152 | Abnormal biliary tract physiology (HP:0012439) | 1.73843103 |
| 153 | Bile duct proliferation (HP:0001408) | 1.73843103 |
| 154 | Anomalous pulmonary venous return (HP:0010772) | 1.73329406 |
| 155 | Atonic seizures (HP:0010819) | 1.72781805 |
| 156 | Pheochromocytoma (HP:0002666) | 1.71223169 |
| 157 | Epileptic encephalopathy (HP:0200134) | 1.71197090 |
| 158 | Hyperventilation (HP:0002883) | 1.70515793 |
| 159 | Abnormality of the columella (HP:0009929) | 1.68616228 |
| 160 | Metaphyseal dysplasia (HP:0100255) | 1.68200778 |
| 161 | Spastic paraparesis (HP:0002313) | 1.67485709 |
| 162 | Adrenal hypoplasia (HP:0000835) | 1.66068333 |
| 163 | Increased circulating renin level (HP:0000848) | 1.65569504 |
| 164 | Neuroendocrine neoplasm (HP:0100634) | 1.64784220 |
| 165 | Progressive external ophthalmoplegia (HP:0000590) | 1.63154687 |
| 166 | Nasolacrimal duct obstruction (HP:0000579) | 1.59653556 |
| 167 | Patchy hypopigmentation of hair (HP:0011365) | 1.59390730 |
| 168 | Hypomagnesemia (HP:0002917) | 1.58272952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 8.07224808 |
| 2 | NME2 | 4.29196504 |
| 3 | VRK2 | 3.92087428 |
| 4 | STK39 | 3.80001140 |
| 5 | TNIK | 3.03805416 |
| 6 | MST4 | 2.93532652 |
| 7 | OXSR1 | 2.75127038 |
| 8 | MUSK | 2.50593292 |
| 9 | MAPKAPK5 | 2.47212598 |
| 10 | CASK | 2.29547916 |
| 11 | STK16 | 2.24168884 |
| 12 | IRAK3 | 2.19731890 |
| 13 | BCKDK | 2.07061329 |
| 14 | CDC7 | 2.05285469 |
| 15 | EIF2AK1 | 1.98983017 |
| 16 | BCR | 1.89632971 |
| 17 | PBK | 1.87483054 |
| 18 | TIE1 | 1.80527067 |
| 19 | TESK1 | 1.80375044 |
| 20 | ILK | 1.73260120 |
| 21 | CDK19 | 1.62688235 |
| 22 | PDK2 | 1.58489566 |
| 23 | TAOK2 | 1.57533285 |
| 24 | MAPK15 | 1.51798120 |
| 25 | MAP2K7 | 1.45054102 |
| 26 | NEK2 | 1.44160540 |
| 27 | WNK4 | 1.43609804 |
| 28 | SCYL2 | 1.37639104 |
| 29 | CSNK1G3 | 1.37070709 |
| 30 | KDR | 1.36045867 |
| 31 | EIF2AK3 | 1.28303500 |
| 32 | CCNB1 | 1.25660635 |
| 33 | INSRR | 1.25207421 |
| 34 | MAPK13 | 1.23027712 |
| 35 | MAP3K12 | 1.21831348 |
| 36 | PAK4 | 1.19634706 |
| 37 | MOS | 1.17567676 |
| 38 | BMPR1B | 1.17447834 |
| 39 | PNCK | 1.14296166 |
| 40 | PKN1 | 1.14210067 |
| 41 | TLK1 | 1.13355325 |
| 42 | TEC | 1.12910846 |
| 43 | MKNK1 | 1.12537806 |
| 44 | NEK6 | 1.08931837 |
| 45 | MAP3K3 | 1.05768941 |
| 46 | CSNK1G2 | 1.05602697 |
| 47 | PRPF4B | 1.04475618 |
| 48 | SRPK1 | 1.03051257 |
| 49 | ABL2 | 1.02802040 |
| 50 | RPS6KA5 | 1.02403677 |
| 51 | PLK3 | 1.02314524 |
| 52 | ARAF | 1.01789688 |
| 53 | NME1 | 1.00800784 |
| 54 | CSNK1G1 | 1.00285585 |
| 55 | ZAK | 0.99796996 |
| 56 | CSNK1A1L | 0.99424136 |
| 57 | ADRBK2 | 0.99302046 |
| 58 | PLK1 | 0.98719519 |
| 59 | NEK9 | 0.97491131 |
| 60 | TTK | 0.95680370 |
| 61 | WEE1 | 0.95464522 |
| 62 | UHMK1 | 0.95349731 |
| 63 | KIT | 0.94342636 |
| 64 | MARK2 | 0.94083301 |
| 65 | CDK7 | 0.93824718 |
| 66 | VRK1 | 0.93703098 |
| 67 | DYRK2 | 0.93465579 |
| 68 | STK24 | 0.92805266 |
| 69 | DAPK3 | 0.92787937 |
| 70 | CAMK2B | 0.90526478 |
| 71 | TTN | 0.90487440 |
| 72 | FRK | 0.90165571 |
| 73 | SIK3 | 0.89086900 |
| 74 | BMPR2 | 0.88455118 |
| 75 | STK4 | 0.88204416 |
| 76 | GRK5 | 0.87868610 |
| 77 | TBK1 | 0.86106669 |
| 78 | FES | 0.86097679 |
| 79 | AURKB | 0.85189390 |
| 80 | TYK2 | 0.84913459 |
| 81 | BRSK1 | 0.84200173 |
| 82 | PIM2 | 0.83746964 |
| 83 | IKBKB | 0.83564104 |
| 84 | TAOK3 | 0.80720827 |
| 85 | AURKA | 0.79351990 |
| 86 | LIMK1 | 0.78853499 |
| 87 | PLK4 | 0.78507716 |
| 88 | WNK1 | 0.78101365 |
| 89 | EPHB1 | 0.78024139 |
| 90 | CDK8 | 0.77884288 |
| 91 | FGR | 0.77828043 |
| 92 | SGK494 | 0.77640140 |
| 93 | SGK223 | 0.77640140 |
| 94 | TAF1 | 0.77334821 |
| 95 | MAPKAPK3 | 0.75395467 |
| 96 | ROCK2 | 0.74781777 |
| 97 | STK10 | 0.73885151 |
| 98 | GRK7 | 0.73871763 |
| 99 | CDK4 | 0.70826801 |
| 100 | PAK1 | 0.70689431 |
| 101 | FGFR2 | 0.69064710 |
| 102 | PLK2 | 0.66889520 |
| 103 | GRK1 | 0.66381906 |
| 104 | CAMK2D | 0.66148007 |
| 105 | LRRK2 | 0.66092017 |
| 106 | SIK2 | 0.65286144 |
| 107 | DAPK1 | 0.64293662 |
| 108 | CAMK2A | 0.64007280 |
| 109 | MAP3K4 | 0.63860573 |
| 110 | MAP3K8 | 0.62965937 |
| 111 | PRKCE | 0.62691769 |
| 112 | PHKG1 | 0.62641167 |
| 113 | PHKG2 | 0.62641167 |
| 114 | CLK1 | 0.61138448 |
| 115 | RAF1 | 0.59127426 |
| 116 | NTRK3 | 0.58700503 |
| 117 | ATR | 0.57985658 |
| 118 | NUAK1 | 0.57770792 |
| 119 | MKNK2 | 0.57247263 |
| 120 | TRIM28 | 0.57043438 |
| 121 | CSNK2A1 | 0.56236832 |
| 122 | ERBB4 | 0.55956892 |
| 123 | MYLK | 0.55375960 |
| 124 | CAMK2G | 0.55013544 |
| 125 | RPS6KB2 | 0.54746750 |
| 126 | PRKCQ | 0.54341143 |
| 127 | TESK2 | 0.53668981 |
| 128 | AKT2 | 0.52807845 |
| 129 | STK3 | 0.52305720 |
| 130 | MAP3K6 | 0.51837607 |
| 131 | BUB1 | 0.50736949 |
| 132 | EIF2AK2 | 0.50664743 |
| 133 | CSNK2A2 | 0.49646681 |
| 134 | CHEK2 | 0.48826070 |
| 135 | CDK9 | 0.48220767 |
| 136 | CAMKK2 | 0.47589339 |
| 137 | CSF1R | 0.46784898 |
| 138 | PINK1 | 0.46373026 |
| 139 | PASK | 0.45984467 |
| 140 | MELK | 0.44644654 |
| 141 | CDK3 | 0.44175650 |
| 142 | MAPK11 | 0.43874217 |
| 143 | ERN1 | 0.43681742 |
| 144 | YES1 | 0.43642778 |
| 145 | DDR2 | 0.43441382 |
| 146 | BLK | 0.42675400 |
| 147 | MAP3K5 | 0.42362305 |
| 148 | EPHA4 | 0.42065352 |
| 149 | CAMK1 | 0.39114087 |
| 150 | CHEK1 | 0.38989233 |
| 151 | PIK3CG | 0.38956544 |
| 152 | DMPK | 0.37452910 |
| 153 | PRKACB | 0.37229165 |
| 154 | MAP2K3 | 0.36926955 |
| 155 | MAP3K1 | 0.34664063 |
| 156 | CDK5 | 0.33277095 |
| 157 | TXK | 0.33115689 |
| 158 | MAPK4 | 0.30751963 |
| 159 | PRKCG | 0.30604536 |
| 160 | PRKACA | 0.30520418 |
| 161 | MARK1 | 0.30389079 |
| 162 | OBSCN | 0.30175216 |
| 163 | BRAF | 0.27931265 |
| 164 | MAP3K2 | 0.27602842 |
| 165 | DYRK1A | 0.27230125 |
| 166 | PRKG1 | 0.27008683 |
| 167 | MET | 0.25341111 |
| 168 | TSSK6 | 0.25301087 |
| 169 | IKBKE | 0.25260299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.50496293 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.74898674 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.73044724 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.70974156 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.48126268 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.47883103 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.99410329 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.92641407 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.60153935 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.48887517 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.36946504 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.36124975 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.30703465 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.20239361 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 2.18566377 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.10433888 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 2.05565174 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.75639771 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73985588 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71802061 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63041966 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.56002291 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.54201835 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.51885973 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.51202234 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.51008880 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49601387 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45430502 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.38450768 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.36319463 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.34892470 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.33925464 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32262845 |
| 34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.30276225 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.27767566 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.26246460 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25666361 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21583352 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 1.21089073 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20159478 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15898538 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15607422 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14105321 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.14069113 |
| 45 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.13551398 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11719950 |
| 47 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.06243690 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 1.05909454 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 1.03310372 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02915643 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02538277 |
| 52 | GABAergic synapse_Homo sapiens_hsa04727 | 1.00119035 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98389457 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.98000252 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97867547 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92556597 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87915603 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87514250 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86341128 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86161055 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83920405 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83000997 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82997597 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81281083 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 0.80750674 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79278800 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78910391 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77128751 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.75925818 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74667797 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72919938 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72830236 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72771696 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.72158255 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.71603959 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71200140 |
| 77 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70137399 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69490323 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69300287 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68198903 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | 0.67863669 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67521519 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.65712106 |
| 84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64653753 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64271514 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.64092445 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63514890 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61992260 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60703543 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60133127 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59934004 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58791430 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.57987192 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57803535 |
| 95 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57603270 |
| 96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55900552 |
| 97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53777719 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52897232 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.52629565 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51886373 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51838976 |
| 102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51645586 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51244706 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.49631830 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49406240 |
| 106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49104913 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49054946 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48454332 |
| 109 | Axon guidance_Homo sapiens_hsa04360 | 0.48043471 |
| 110 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46972826 |
| 111 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46530826 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46371301 |
| 113 | DNA replication_Homo sapiens_hsa03030 | 0.45476815 |
| 114 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45320431 |
| 115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45169850 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45099943 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44464602 |
| 118 | Allograft rejection_Homo sapiens_hsa05330 | 0.44397966 |
| 119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44178815 |
| 120 | Taste transduction_Homo sapiens_hsa04742 | 0.43040724 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.42611782 |
| 122 | Mismatch repair_Homo sapiens_hsa03430 | 0.41319900 |
| 123 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37680112 |
| 124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35810787 |
| 125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35790252 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35495113 |
| 127 | Spliceosome_Homo sapiens_hsa03040 | 0.34916802 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33141575 |
| 129 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33014484 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32918026 |
| 131 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32665238 |
| 132 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32285916 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.32241713 |
| 134 | Malaria_Homo sapiens_hsa05144 | 0.31289246 |
| 135 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30908129 |
| 136 | Shigellosis_Homo sapiens_hsa05131 | 0.30348770 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28707636 |
| 138 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28678139 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28202928 |
| 140 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.27164686 |
| 141 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.27064058 |
| 142 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27034645 |
| 143 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.25875297 |
| 144 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25802791 |
| 145 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24816595 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23653112 |
| 147 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.23547897 |
| 148 | Renin secretion_Homo sapiens_hsa04924 | 0.22895016 |
| 149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22890759 |
| 150 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.22683048 |
| 151 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.19268339 |
| 152 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18568363 |

